Management
Extensive Experience. Proven Execution.
Henry Wu



Education
- Rutgers University, Ph.D. in Biostatistics
- Tsinghua University, BS in Electrical Engineering and Industrial Engineering
Industry Experience
- 19 years of industry experience, worked at Pfizer and Roche
- 2003-2010 Founded a statistical consulting firm in the US
- 2010-2016 Head of the K&L data and statistics division
- 2013-2016 COO and CEO of Fountain Medical Development
Achievements
- Led and completed more than 25 statistical and analysis projects in FDA/EMA NDA applications
Yiren Dai



Education
- MBA, Business Administration, University of Michigan
- BS, Sport Physiology and Biochemistry, Beijing Sport University
Industry Experience
- Experienced in strategic management, industrial operation, and system compliance
- Experienced in systematic corporate development, strategic market planning
- China CEO of DJO Global, a leading medical device manufacturer of the world, fully responsible for China’s business including founding the team, and achieving outstanding
- Managing Director, Highlight Capital, which focuses on the early investment of innovative products and services for health
- Multiple roles at Johnson & Johnson, Director of Corporate Strategic Account, Business department Head of Neurosurgery and Interventional Therapy
- Product Manager, Nike China, laid a foundation of China’s business development
Jim Xu



Education
-
- MBA, The University of Chicago University, School of Business
-
- M.S., Chemistry, University of Toledo, Ohio, USA
-
- B.S., Food Engineering, Tianjin Science and Technology University, China
Industry Experience
-
-
- Has abundant experience in management, forwarded-looking on business strategy and development.
-
-
-
- Has made remarkable achievements in previous working experiences.
-
-
-
- General Manager of Medidata (Shanghai) Technology Co., LTD. Led the overall business development of Medidata in China.
-
-
-
- General Manager for Greater China of Caradigm (Beijing) Technology Co., LTD. Successfully transformed Caradigm from a foreign company to a Start-Up company.
-
-
-
- General Manager of Microsoft Healthcare Group, Greater China.
-
-
-
- General Manager of Value CT for GE Healthcare.
-
-
- In the early stage of his career in the U.S, Served as the Product Manager of Advanced Chemtech and Marketing Manager of Sigma-Aldrich.
Xinping Fang



Education
- PhD, Natural Product Chemistry & Spectroscopy, Purdue University
- MS, Pharmacognosy, West China University of Medical Sciences
Industry Experience
- 25+ years of experience in Bioanalysis, drug metabolism, toxicokinetics and pharmacokinetics in Pharma and CRO in the U.S. and China
- Participated in dozens of new drug development projects and the development and application of hundreds of biological sample analysis methods in the U.S. and China
- Served as a Global Head of WuXi AppTec’s Testing Division and Biological Sample Analysis Service Department; Was responsible for the management of more than 80 LC-MS/MS systems and 400 employees in three branches in Shanghai, Suzhou, and New Jersey
- Served as the Vice President of XenoBiotic Laboratories, Inc. in New Jersey, in charge of the operation of biological sample analysis service and drug metabolism department
- Served as Vice General Manager of Nanjing XBL-China Company, the Vice Director of biological sample analysis in the DMPK department of Novartis, the Assistant Director of biological sample analysis in Purdue Pharmaceuticals, and the Pharmacokinetic Researcher of FMC R&D Center
Lijun Xiao



Education
Jiamusi Medical College, Bachelor of Pharmacy
Industry Experience
27 years of industry experience, 18 years of regulatory registration experience and 9 years of preclinical research and development experience
Deputy Director, Director and Senior Director of Fountain Medical Pharmaceuticals Registration Department
Successfully filed IND and NDA applications for dozens of chemical and biological products as well as imported drugs. Participated in early clinical development for dozens of innovative drugs as a strategic advisor.
Registered hundreds of pharmaceutical products
Successfully completed US-China dual registration for multiple products
Richard Zhang



Education
Shenyang Pharmaceutical University, Bachelor of Pharmaceutical Engineering
Industry Experience
VP of Pharmaron, currently responsible for Pharmaron and its subsidiaries’ clinical work, such as formulation of clinical trial strategies, clinical trial planning and execution, test drug supply chain management, quality management and etc.
Worked in several leading global and domestic pharmaceutical companies, engaged in team management and project management, and worked in foreign headquarters.
Managed and participated in nearly 50 clinical trial projects, involving different treatment areas, such as tumor, digestion, endocrine, rheumatism, reproductive health, mental, infection and etc.
Achievements
Served as the chairman and speaker of the DIA annual meeting branch venue many times, and also the member and speaker of the organizing committee at domestic academic conferences.
Served as deputy leader of the project management team in Shanghai Pharmaceutical Association’s Clinical Research Special Committee and special lecturer in Huashan Hospital of Fudan University.
Mandy Xu



Education
Peking University School of Medicine, Pharm.D
Industry Experience
11 years of pharmacokinetics research, regulatory experience and bioanalytical management experience, including ADME screening platform, IND DMPK filing, and regulatory bioanalysis to support GLP toxicology and clinical research
Vice President, DMPK and Regulatory Bioanalysis, Pharmaron
Head of Clinical Bioanalytical Testing Laboratory, Pharmaron, with extensive experience in the fields of biotransformation, ADME, and drug-drug interaction
Familiar with pre-clinical and clinical registration of innovative drugs with NMPA and FDA submissions
Yumei Peng



Education
Xi’an Jiaotong University, Master of Bioengineering, Genetic Statistics
Xi’an Jiaotong University, Bachelor of Bioengineering
Industry Experience
Over 10 years of biostatistics and programming experience.
Pharmaceutical Biostatistics Manager, Senior Manager and Director in MacroStat, Fountain Medical Development.
Responsible for statistics and programming of multiple Phase I to IV international and domestic projects (involving different therapeutic areas), 2 US NDA submissions and multiple Chinese NDA submissions.
Pei-Yun Chen



Education
North Carolina State University, Ph.D. in Biostatistics
National Chengchi University, MBA in Statistics
National Taiwan University, Bachelor of Mathematics
Industry Experience
Over 18 years of experience in biostatistics industry.
Senior Statistician, Deputy Director of Statistics, Director and Senior Director in Merck, FMD K&L.
Participated in multiple FDA NDA submissions across various therapeutic areas.